Description
This is an overview of current clinical trial regulations and guidance documents in Canada, including Division 5 of the Food and Drugs Regulations, ICH GCP E6, and related guidances, such as the importation policy, labelling of investigational products, and the unique Health Canada requirements for clinical trial record retention.
Speaker(s):
- Patricia
Jones,
ART, RAC,
Director, Quality and Regulatory Compliance,
Therapeutic Products, Inc. (TPIreg)
Speaker(s):
